AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca geographic Operating Profit — Europe ex-UK ($M) ($M)
Form 20-F Note 29 Geographic Information (Postgres DB)
Latest, FY2025
5,233
Period ended Dec 31, 2025
Change on a year earlier
-11.7%
5,924 in FY2024
History
6 years
Since FY2020
Sources
4
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Geographic Operating Profit — Europe ex-UK ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5,233 | -11.7% | Form 20-F (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 5,924 | +21.3% | Form 20-F (filed 2025-02-18) ↗ |
| FY2023 | Dec 31, 2023 | 4,885 | +65.9% | Form 20-F (filed 2024-02-20) ↗ |
| FY2022 | Dec 31, 2022 | 2,945 | -1.8% | Form 20-F (filed 2023-02-21) ↗ |
| FY2021 | Dec 31, 2021 | 2,999 | +5.7% | Form 20-F (filed 2023-02-21) ↗ |
| FY2020 | Dec 31, 2020 | 2,838 | – | Form 20-F (filed 2023-02-21) ↗ |
Cite this data
StockData. (2026). AstraZeneca Geographic Operating Profit — Europe ex-UK ($M) ($M), annual FY2020–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/seg_geo_eu_op
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.